|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.38 DKK | +1.36% |
|
-0.98% | -6.44% |
| 23/03 | H. Lundbeck Price Target Down as AlphaValue/Baader Europe Expects Patent Expirations to Weigh on Growth | MT |
| 20/03 | H Lundbeck: Markets need more proof of growth promise |  |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Research, Development, Production and Sale of Pharmaceuticals | 1.63TCr | 1.82TCr | 1.99TCr | 2.2TCr | 2.46TCr | |||||
Total Assets | 3.47TCr | 3.75TCr | 3.74TCr | 5.7TCr | 5.21TCr | |||||
Interest Expense | -15Cr | -10Cr | -5.4Cr | -11Cr | -51Cr | |||||
Income Tax Expense | 26Cr | 56Cr | 70Cr | 58Cr | 129.5Cr | |||||
CAPEX | -61Cr | -82Cr | -28Cr | -51Cr | -55Cr | |||||
EBT | 158.1Cr | 247.4Cr | 299.3Cr | 371.9Cr | 448.7Cr | |||||
Gross Profit | 1.27TCr | 1.43TCr | 1.54TCr | 1.78TCr | 2.04TCr | |||||
D&A | 170.7Cr | 180.7Cr | 201.2Cr | 187.6Cr | 186.5Cr | |||||
Operating Income | 201Cr | 285.2Cr | 319.5Cr | 327Cr | 527.5Cr | |||||
Net Income | 131.8Cr | 191.6Cr | 229Cr | 314.3Cr | 319.2Cr |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 745.6Cr | 910.2Cr | 982.9Cr | 1.13TCr | 1.33TCr | |||||
Total Assets | 1.28TCr | 1.31TCr | 1.2TCr | 3.29TCr | 2.92TCr | |||||
Europe | - | 425.2Cr | 462.8Cr | 514.6Cr | 581.9Cr | |||||
International Operations | 415.5Cr | 520.3Cr | 499.1Cr | 521.9Cr | 485.8Cr | |||||
Total Assets | 180.9Cr | 155.2Cr | 152.6Cr | 152.5Cr | 105.4Cr | |||||
Unallocated | 40Cr | -31Cr | 46Cr | 31Cr | 67Cr | |||||
Unallocated Effects from Hedging | - | - | - | - | - | |||||
North America (Excl. US) | 79Cr | - | - | - | - | |||||
Unallocated Other Revenue | - | - | - | - | - | |||||
Europe (Excl.Denmark) | 346.9Cr | - | - | - | - | |||||
Denmark | 3Cr | - | - | - | - | |||||
Total Assets | 1.11TCr | 1.08TCr | 1TCr | 893.1Cr | 851.5Cr |
- Stock Market
- Equities
- HLUN B Stock
- Financials H. Lundbeck A/S
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition